This is particularly important for individuals with pre-existing medical conditions such as heart disease, hypertension, diabetes, thyroid disorders, or mental health conditions, as certain supplement ingredients may interact with prescribed medications or exacerbate underlying health issues
This dual actioncentral nervous system signaling combined with peripheral gastrointestinal effectscreates a comprehensive weight management effect
However, Eli Lilly's existing GLP-1 franchise generated $36.5 billion in 2025, analysts project retatrutide could add $15+ billion annually, and the combined obesity drug market is projected to reach $101 billion in peak annual sales
FDA approves Ozempic (semaglutide) for type 2 diabetes. December 5, 2017
It has to be about, like, something else